Back to the overview page

Marie-José (MJ) Claessen MD

Department
Hematopoiesis
E-mail
m.claessen2@sanquin.nl
LinkedIn
https://www.linkedin.com/in/mjclaessen/
Training

MSc Biomedical Sciences, University of Utrecht.
Medicine, University of Utrecht

Research interests

Hematopoiesis

Technology

Cell culture
Flow cytometry
Protein precipitation
Lipidomics
Proteomics

Resume
2016-current PhD student, Sanquin Research, Department of Haematopoiesis
2016-current  Internist-Haematologist, Academic Medical Centre Amsterdam
2016 Internist-Haematologist, Isala Zwolle
2015-2016 Internist-Haematologist, Erasmus MC Rotterdam, Daniel den Hoed location
2013-2015 Internist-Haematologist, Erasmus MC Rotterdam, Dijkzigt Location
2011-2013  AIOS internal medicine, focus haematology, University Medical Centre Utrecht
2010-2011 AIOS internal medicine, University Medical Centre Utrecht
2008-2010 AIOS internal medicine, Meander Medical Center, Amersfoort
2006-2007  ANIOS internal medicine, cardiology and pulmonary diseases, Gelderse Vallei, Ede
Publications
Sanquin publications
Other publications

Ten Brink F, Rijneveld AW, Claessen MJAG, Heesterman AJ, Van Zon TJ, Teuben SAMC , Onna Van - Walraven CJD, Goncalves Silva AMA , Van Veelen F, Du Mortier R, Joosten MAMS, Petrij F, Hazelzet JA, Cnossen MH. Value-Based Health Care (VBHC) in Sickle Cell Disease: A Dutch Initiative. Blood 2015;126:5572.

Claessen MJAG, Hagenbeek A, Lugtenburg PJ. Brentuximab Vedotin, een nieuwe therapeutische optie voor patiƫnten met een CD30-positief lymfoom. Ned Tijdschr Hematol 2015;12(4)

Van Meerten T, Claessen MJ, Hagenbeek A, Ebeling SB. The CD20/aCD20 'suicide' system: novel vectors with improved safety and expresion profiles and efficient elimination of CD20-transgenic T cells. Gene Ther 2006;13(9);789-97

Last edited on: 1 June 2017
Back to the overview page